Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma [Phase 3]
Phase 3 clinical trial evaluating perioperative chemotherapy in patients with CINSARC high-risk localized soft tissue sarcoma; currently rec…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating retifanlimab in combination with gemcitabine and docetaxel for advanced soft tissue sarcoma; the study…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy [EARLY_Phase 1]
An early-phase clinical trial at Thomas Jefferson University is evaluating contrast-enhanced ultrasound to monitor soft tissue sarcoma respo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding abemaciclib to gemcitabine for soft tissue sarcoma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) [Phase 2]
A Phase 2 clinical trial update on rogaratinib (BAY 1163877) for FGFR1-4-altered advanced sarcoma and SDH-deficient gastrointestinal stromal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lurbinectedin + Doxorubicin In Leiomyosarcoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating lurbinectedin in combination with doxorubicin for advanced or metastatic soft-tissue sarcoma, including leiomyo…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: 5-Day Preoperative Radiation for Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating a 5-day preoperative radiation regimen for soft tissue sarcoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial [Phase 2]
This is a Phase 2 clinical trial (AXIOM) sponsored by the National Cancer Institute evaluating atezolizumab plus selinexor for alveolar soft…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma [Phase 1]
Phase 1 trial evaluating the safety of low-dose pegylated liposomal doxorubicin in combination with peposertib for advanced sarcoma; current…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery [Phase 2]
Clinical trial update for a Phase 2 study evaluating Talimogene laherparepvec with radiation therapy in newly diagnosed soft tissue sarcoma …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment [Phase 2]
Phase 2 trial evaluating Cadonilimab plus Anlotinib in advanced soft tissue sarcoma after failure of first-line therapy. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Exercise and Soft Tissue Sarcoma [NA]
Duke University is conducting a recruiting clinical trial to study the effects of exercise in patients with soft tissue sarcoma.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas [Phase 2]
Phase 2 clinical trial evaluating Cirtuvivint in selected advanced soft tissue sarcomas is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants [Phase 1]
Phase 1 study evaluating autologous tumor-infiltrating lymphocytes in pediatric, adolescent, and young adult participants with soft tissue s…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) [NA]
Clinical trial update for the DaRT alpha radiation emitter device from Alpha Tau Medical for treating skin cancer, oral cavity mucosal cance…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions [NA]
Status update for a clinical trial evaluating neoadjuvant ion therapy as irradiation for extremity soft tissue sarcoma; the study is current…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials [NA]
A clinical trial update describing efforts to improve adolescent and young adult self-reported data in ECOG-ACRIN trials, with trials curren…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Registry-based clinical trial update for the Epithelioid Hemangioendothelioma Registry within EURACAN, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall [Phase 2]
A Phase 2 clinical trial is assessing the long-term efficacy of moderately hypofractionated neoadjuvant radiotherapy for soft tissue sarcoma…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) [Phase 2]
A Phase 2 clinical trial (neoSFRT-SARC) evaluating preoperative spatially fractionated radiation therapy in soft tissue sarcoma is currently…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma [Phase 2]
A Phase 2 study evaluating preoperative 5-day radiotherapy for soft tissue sarcoma. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study [Phase 4]
This ClinicalTrials.gov entry reports a Phase 4 pilot study evaluating hyperbaric oxygen therapy for soft tissue sarcoma, currently active b…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
Phase 2 pediatric MATCH trial evaluating IDH1-mutant tumors for response to ivosidenib; results for recurrent and refractory solid tumors, l…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma [Phase 2]
A Phase 2 clinical trial in patients with metastatic or locally advanced leiomyosarcoma (including leiomyosarcoma of the ovary and soft tiss…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial [Phase 2]
This is a Phase II clinical trial evaluating Nano-Carbon Iron Suspension Injection in combination with radiotherapy for solid tumors. The st…